Versor Investments’s Kite Pharma, Inc. KITE Stock Holding History

Versor Investments’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-92,638	Closed	-$16.7M	–	317
2017 Q3	$16.7M	Buy	+92,638	New	+$12.9M	5.44%	2

Versor Investments's KITE Position: Q4 2017 in Review

Versor Investments sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 92,638 shares — an estimated $16.7M sold.

Versor Investments first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $16.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Versor Investments reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Versor Investments sold 92,638 Kite Pharma, Inc. shares in Q4 2017, an estimated $16.7M.
Versor Investments first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Versor Investments's Kite Pharma, Inc. position peaked at $16.7M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Versor Investments's 13F filing for Q4 2017, filed 9 Feb 2018.